A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)

Clinical Site, Oceanside

Clinical Site, Westbury

Clinical Site, Liverpool

Clinical Site, Rochester

Clinical Site, Hagerstown

Clinical Site, Fairfax

Clinical Site, Lynchburg

Clinical Site, Winston-Salem

Clinical Site, Wake Forest

Clinical Site, Hickory

Clinical Site, Asheville

Clinical Site, West Columbia

Clinical Site, Charleston

Clinical Site, Ladson

Clinical Site, Florence

Clinical Site, Jacksonville

Clinical Site, Orlando

Clinical Site, Coral Springs

Clinical Site, Fort Lauderdale

Clinical Site, Stuart

Clinical Site, Germantown

Clinical Site, Jackson

Clinical Site, Lexington

Clinical Site, Carmel

Clinical Site, Saint Louis Park

Clinical Site, Edina

Clinical Site, Rapid City

Clinical Site, Oak Forest

Clinical Site, Lenexa

Clinical Site, Edmond

Clinical Site, Dallas

Clinical Site, Arlington

Clinical Site, The Woodlands

Clinical Site, Bellaire

Clinical Site, Beaumont

Clinical Site, San Antonio

Clinical Site, San Antonio

Clinical Site, Round Rock

Clinical Site, Austin

Clinical Site, Abilene

Clinical Site, Willow Park

Clinical Site, Lakewood

Clinical Site, Colorado Springs

Clinical Site, Salt Lake City

Clinical Site, Albuquerque

Clinical Site, Beverly Hills

Clinical Site, Long Beach

Clinical Site, Arcadia

Clinical Site, Pasadena

Clinical Site, Poway

Clinical Site, Huntington Beach

Clinical Site, Laguna Hills

Clinical Site, Bakersfield

Clinical Site, Oakland

Clinical Site, Modesto

Clinical Site, Sacramento

Clinical Site, Bellevue

Clinical Site, Silverdale

Clinical Site, Waterford

Clinical Site, Oak Park

Clinical Site, Teaneck